China Approves Local Generics Of Glivec; Novartis Says Quality Doesn’t Come Close
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis plans to draw on the safety profile of Glivec and a patient assistance program to ward off new competitors in China.